Development and Validation of an Explainable Machine Learning-Based Prediction Model for Drug–Food Interactions from Chemical Structures

Abstract

Possible drug–food constituent interactions (DFIs) could change the intended efficiency of particular therapeutics in medical practice. The increasing number of multiple-drug prescriptions leads to the rise of drug–drug interactions (DDIs) and DFIs. These adverse interactions lead to other implications, e.g., the decline in medicament’s effect, the withdrawals of various medications, and harmful impacts on the patients’ health. However, the importance of DFIs remains underestimated, as the number of studies on these topics is constrained. Recently, scientists have applied artificial intelligence-based models to study DFIs. However, there were still some limitations in data mining, input, and detailed annotations. This study proposed a novel prediction model to address the limitations of previous studies. In detail, we extracted 70,477 food compounds from the FooDB database and 13,580 drugs from the DrugBank database. We extracted 3780 features from each drug–food compound pair. The optimal model was eXtreme Gradient Boosting (XGBoost). We also validated the performance of our model on one external test set from a previous study which contained 1922 DFIs. Finally, we applied our model to recommend whether a drug should or should not be taken with some food compounds based on their interactions. The model can provide highly accurate and clinically relevant recommendations, especially for DFIs that may cause severe adverse events and even death. Our proposed model can contribute to developing more robust predictive models to help patients, under the supervision and consultants of physicians, avoid DFI adverse effects in combining drugs and foods for therapy.

Linc2function: A Comprehensive Pipeline and Webserver for Long Non-Coding RNA (lncRNA) Identification and Functional Predictions Using Deep Learning Approaches

“…Further, the performance evaluation of all the models is summarized in Table 2 , which presents key metrics, including precision, recall (also known as sensitivity), specificity, F1 score, and AUROC. These metrics collectively provide an informative assessment of the models’ effectiveness [ 43 , 44 ].…”

Application of artificial neural network in daily prediction of bleeding in ICU patients treated with anti-thrombotic therapy

“…Therefore, we need a larger dataset to avoid data bias. External validation work similar to the one reported in this literature, such as a prediction model for avoiding the occurrence of adverse reactions when drugs and food are used together [ 33 ]. Finally, the interpretability of recurrent neural networks can be challenging due to their inherent complexity, particularly in relation to time step folding.…”

Machine learning unveils immune-related signature in multicenter glioma studies

“…Its applications range from predicting protein crystallization processes and assessing drug-food interactions to evaluating cancer prognosis in types such as triple-negative breast cancer and lung adenocarcinoma. 31 , 32 , 33 , 34 Notably, machine learning has been instrumental in delineating tumor-infiltrating immune cell signatures in gliomas, offering deeper insights into the interactions within the TME. 35 , 36 These advancements demonstrate the versatility and efficacy of machine learning methods in addressing the intricacies of complex diseases like glioma.…”